-
January 13, 2015
2014 is yet another year lost for the Health reform The intentions for changes in health care are serious, stated Minister Petar Moskov The shadow of the health reform began to appear on the threshold of the new 2015. Obviously discussions on serious reforms have a slow start and this was evident in the last […]
-
The NHIF will pay 100% the covered medicines not to the pharmacies but to the producer The general practitioners, who treat patients in remote areas of Bulgaria, will be allowed to sell medicinal products to patients – irrespective of whether the medicines are prescription or not. This is foreseen in the amendments that the parliamentary […]
-
Telmisartan, which relates to the group of angiotensin receptor blockers (ARB), is distinguished from other sartans with its optimal pharmacokinetic profile and with some unique pharmacodynamic characteristics. Thanks to this, telmisartan has favorable gluco-metabolic effects – cardiometabolic sartan, and can be regarded as an antihypertensive agent of choice in patients with the simultaneous presence of […]
-
Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes. Tchaikapharma High Quality Medicines Inc. received new Marketing Authorization for the medicinal product Pizona 15 mg, Pizona 30 mg and Pizona 45 mg tablets subject to medical prescription. Pizona contains the active substance pioglitazone and is an anti-diabetic medicine […]
-
December 16, 2014
The team of “Tchaikapharma High Quality Medicines” wishes you warm and happy Christmas and New Year holidays!